Intermediate Pituitary Cells, also known as gonadotrophs, constitute a crucial subset of cells in the anterior pituitary gland, a master endocrine organ. These cells play a pivotal role in regulating reproductive functions by secreting gonadotropins—luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH act on the gonads (testes in males and ovaries in females), influencing gamete production and steroid hormone release. Unlike other pituitary cell types, intermediate cells exhibit a unique mix of characteristics, expressing both folliculo-stellate and endocrine cell markers. The secretion of gonadotropins is tightly regulated by the hypothalamus through the release of gonadotropin-releasing hormone (GnRH). In males, LH stimulates the production of testosterone, crucial for spermatogenesis, while FSH supports the maturation of sperm. In females, FSH prompts follicular development in the ovaries, while LH triggers ovulation and promotes the formation of the corpus luteum. Dysfunction in intermediate pituitary cells can lead to reproductive disorders, impacting fertility and hormonal balance. Understanding the intricate regulation and functions of these cells is essential for comprehending reproductive physiology and developing interventions for conditions related to hormonal imbalances in both men and women.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy